Mi. Filipe et al., EXPRESSION OF A PEPTIDE EPITOPE OF THE COLONIC MUCIN MUC2 IN PRECURSOR LESIONS TO GASTRIC-CARCINOMA, European journal of cancer prevention, 5(4), 1996, pp. 287-295
Previous histochemical studies have shown that changes occur in the co
mposition of mucins both in preneoplastic and neoplastic lesions of th
e gastric mucosa, Since monoclonal antibodies are now available which
recognize the protein product of distinct mucin genes, they are likely
to provide useful tools for evaluating these changes, Thus, a monoclo
nal antibody 996/1 raised against a peptide epitope of the colonic muc
in MUC2 was examined for its potential as a prognostic indicator in ga
stric cancer, 996/1 works well on formalin-fixed paraffin sections and
shows good staining of the colonic goblet cells in the region of the
golgi, while there is no staining of normal control gastric mucosa, Th
e epitope was detected in all cases of intestinal metaplasia (44 sampl
es) and some but not all cases of dysplasia (26 samples) and gastric c
arcinoma (74 samples), There was no significant difference between the
positivity of the tumours according to their classification, stage an
d lymph node status, These results unfortunately gave little indicatio
n that this antibody would be a useful prognostic tool in gastric canc
er, However, the pattern of 996/1 staining provides useful information
about the molecular changes in mucin expression that occur in gastric
carcinogenesis.